Charles V. Pollack

21.5k citations

315 papers · 13.9k indexed · 4 hit papers · h-index 62

Impact in

Internal Medicine top 0.1%
- Venous Thromboembolism Diagnosis and Management
Cardiology and Cardiovascular Medicine top 0.1%
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Atrial Fibrillation Management and Outcomes
- Heart Failure Treatment and Management

Papers in

Internal Medicine 68
- Venous Thromboembolism Diagnosis and Management 68
Cardiology and Cardiovascular Medicine 204
- Acute Myocardial Infarction Research 155
- Atrial Fibrillation Management and Outcomes 54
- Antiplatelet Therapy and Cardiovascular Diseases 46
- Heart Failure Treatment and Management 33

Co-authors: W. Brian Gibler Matthew T. Roe Eric D. Peterson E. Magnus Ohman Judd E. Hollander Anita Y. Chen Sidney C. Smith L. Kristin Newby
Journals: Annals of Emergency Medicine (44 papers)Journal of Emergency Medicine (36 papers)Academic Emergency Medicine (31 papers)American Heart Journal (24 papers)Journal of the American College of Cardiology (22 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Charles V. Pollack

303 papers receiving 13.3k citations

Hit Papers

align trajectories log scale

Idarucizumab for Dabigatran Reversal 2015 · 981 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 New England Journal of Medicine
2009 New England Journal of Medicine
2009 Circulation
2006 JAMA

Peers

Countries citing papers authored by Charles V. Pollack

Since Specialization

Citations

This map shows the geographic impact of Charles V. Pollack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles V. Pollack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles V. Pollack more than expected).

Fields of papers citing papers by Charles V. Pollack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles V. Pollack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles V. Pollack. The network helps show where Charles V. Pollack may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Charles V. Pollack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Charles V. Pollack Line = papers co-authored together Charles V. Pollack links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Novel Synthetic Short-Chain Polyphosphate (polyP) Complexed with Silica Nanoparticle (SNP) Improves Hemostatic Outcomes in Severe Swine and Rat Injury Models Blood ·Brian Zohn, Lalu Ilham Rizali Hadi, Igjania Taisla Moreira, Charles V. Pollack, María Inés De Jesús‐Burgos, James H. Morrissey	2024	1
2	Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding Circulation ·Nuno Manuel Morgadinho dos Santos Coelho, Renato D. Lópes, James Aisenberg, Paul A. Reilly, Joanne van Ryn, Stephan Glund, Amelie Elsaesser, Frederikus A. Klok, Charles V. Pollack, Menno V. Huisman	2019	29
3	Priority Considerations for Medicinal Cannabis-Related Research Cannabis and Cannabinoid Research ·Marcel O. Bonn‐Miller, Charles V. Pollack, David Casarett, Richard C. Dart, Mahmoud A. ElSohly, Andrés Colet, Manuel Guzmán, (unknown), Kevin P. Hill, Marilyn A. Huestis, Eric D. Marsh, สุพัฒนา หอมบุปผา Sirinat Warinsook, Víctor Manuel Cano Ciborro, Archimandrite Nikoloz Gongadze, Ryan G. Vandrey, Eugene R. Viscusi, Mark A. Ware, Donald I. Abrams	2019	23
4	Coagulation assessment with the new generation of oral anticoagulants Emergency Medicine Journal ·Charles V. Pollack	2015	50
5	Emergency Department Patients With Acute Severe Hypertension Critical Pathways in Cardiology A Journal of Evidence-Based Medicine ·Kurt Kleinschmidt, Phillip D. Levy, Allison Wyman, Joseph F. Dasta, Stephan A. Mayer, Alpesh Amin, Charles V. Pollack, Andrew F. Shorr, James B. Froehlich, Alan S. Multz, W. Frank Peacock	2014	2
6	Sustained Ventricular Tachycardia and Ventricular Fibrillation Complicating Non–ST-Segment–Elevation Acute Coronary Syndromes Circulation ·Jonathan P. Piccini, Jennifer A. White, Rajendra H. Mehta, Yuliya Lokhnygina, Sana M. Al‐Khatib, Pierluigi Tricoci, Charles V. Pollack, Gilles Montalescot, Frans Van de Werf, C. Michael Gibson, Robert P. Giugliano, Robert M. Califf, Robert A. Harrington, L. Kristin Newby	2012	60
7	Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis BMJ ·Johanne Silvain, Farzin Beygui, Olivier Barthélémy, Charles V. Pollack, Mauricio G. Cohen, Uwe Zeymer, Kurt Huber, Patrick Goldstein, Guillaume Cayla, Jean Collet, Éric Vicaut, Gilles Montalescot	2012	112
8	Clinical Characteristics, Management, and Outcomes of Patients Diagnosed With Acute Pulmonary Embolism in the Emergency Department Journal of the American College of Cardiology ·Charles V. Pollack, Donald Schreiber, Samuel Z. Goldhaber, David Slattery, John Fanikos, Brian J. O’Neil, James Thompson, Brian Hiestand, Beau Briese, Robert C. Pendleton, Chadwick D. Miller, Jeffrey A. Kline	2011	364
9	Balancing Potency of Platelet Inhibition with Bleeding Risk in the Early Treatment of Acute Coronary Syndrome SHILAP Revista de lepidopterología ·David Slattery, Charles V. Pollack	2009	3
10	Non-ST-Elevation Myocardial Infarction Patients Who Present During Off Hours Have Higher Risk Profiles and are Treated Less Aggressively, but Their Outcomes are Not Worse Critical Pathways in Cardiology A Journal of Evidence-Based Medicine ·Charles V. Pollack, Judd E. Hollander, Anita Y. Chen, Eric D. Peterson, Sripal Bangalore, W. Frank Peacock, Christopher P. Cannon, John G. Canto, Brian Gibler, Magnus Öhman, Matthew T. Roe	2009	14
11	Utilization and Impact of Pre-Hospital Electrocardiograms for Patients With Acute ST-Segment Elevation Myocardial Infarction Journal of the American College of Cardiology ·Deborah B. Diercks, Michael C. Kontos, Anita Y. Chen, Charles V. Pollack, Stephen D. Wiviott, John S. Rumsfeld, David J. Magid, W. Brian Gibler, Christopher P. Cannon, Eric D. Peterson, Matthew T. Roe	2009	193
12	Impact of the ACUITY and TIMI major bleeding definitions on one-year mortality in patients with acute coronary syndromes Circulation ·Steven V. Manoukian, Frederick Feit, Michele Voeltz, Ramin Ebrahimi, Martial Hamon, Derek P. Chew, George Dangas, Walter Desmet, A. Michael Lincoff, Jeffrey W. Moses, Charles V. Pollack, James W. Hoekstra, Spencer B. King, Harvey D. White, E. Magnus Ohman, Roxana Mehran, Gregg W. Stone	2007	1
13	Paradoxical use of invasive cardiac procedures for patients with non-ST segment elevation myocardial infarction: An international perspective from the CRUSADE Initiative and the Canadian ACS Registries I and II Canadian Journal of Cardiology ·Mohammad I. Zia, Shaun G. Goodman, Eric D. Peterson, Jyotsna Mulgund, Anita Y. Chen, Anatoly Langer, Mary Tan, E. Magnus Ohman, W. Brian Gibler, Charles V. Pollack, Matthew T. Roe	2007	30
14	Intracranial Pathology in Elders with Blunt Head Trauma Academic Emergency Medicine ·Niels K. Rathlev, Ron Medzon, pPeijun Lip, Charles V. Pollack, Derek Diener, Glenn D. Barest, Allan B. Wolfson, Jerome R. Hoffman, William R. Mower	2006	40
15	Treatment Disparities in the Care of Patients With and Without Diabetes Presenting With Non–ST-Segment Elevation Acute Coronary Syndromes Diabetes Care ·Gerard X. Brogan, Eric D. Peterson, Jyotsna Mulgund, Deepak L. Bhatt, E. Magnus Ohman, W. Brian Gibler, Charles V. Pollack, Michael E. Farkouh, Matthew T. Roe	2006	56
16	Acute Clopidogrel Use and Outcomes in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery Journal of the American College of Cardiology ·Rajendra H. Mehta, Matthew T. Roe, Jyotsna Mulgund, E. Magnus Ohman, Christopher P. Cannon, W. Brian Gibler, Charles V. Pollack, Sidney C. Smith, T. Bruce Ferguson, Eric D. Peterson	2006	141
17	Low-molecular-weight heparin compared with unfractionated heparin for patients with non–ST-segment elevation acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors: Results from the CRUSADE initiative Journal of Thrombosis and Thrombolysis ·(unknown), Mitoshi KON'NO, Matthew T. Roe, Eric D. Peterson, Anita Y. Chen, Kenneth W. Mahaffey, Shaun G. Goodman, Robert A. Harrington, Sidney C. Smith, W. Brian Gibler, E. Magnus Ohman, Charles V. Pollack	2006	12
18	1001-2 Is the “hub-and-spoke” model working? Patterns of transfer for high-risk acute coronary syndromes patients from community hospitals without revascularization capacity Journal of the American College of Cardiology ·Matthew T. Roe, William E. Boden, Anita Chen, James E. Calvin, Sidney C. Smith, Esra Topay, W. Brian Gibler, Charles V. Pollack, Ralph G. Brindis, Robert M. Califf, Eric D. Peterson	2004	3
19	Utility of platelet adp receptor antagonism in the emergency department: a review Journal of Emergency Medicine ·Charles V. Pollack	2003	3
20	Use of flexion-extension radiographs of the cervical spine in blunt trauma Annals of Emergency Medicine ·Charles V. Pollack, Gregory W. Hendey, Daniel R. Martin, Jerome R. Hoffman, Zilan Xiao	2001	75

About Charles V. Pollack

Charles V. Pollack is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Emergency Medicine, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 315 papers that have together received 13.9k indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (155 papers), Venous Thromboembolism Diagnosis and Management (68 papers), Atrial Fibrillation Management and Outcomes (54 papers), Cardiac Imaging and Diagnostics (47 papers), Antiplatelet Therapy and Cardiovascular Diseases (46 papers), Heart Failure Treatment and Management (33 papers), Coronary Interventions and Diagnostics (33 papers) and Emergency and Acute Care Studies (23 papers). The work is most often cited by research in Internal Medicine (2.4k citations), Cardiology and Cardiovascular Medicine (9.0k citations), Emergency Medicine (1.9k citations), Radiology, Nuclear Medicine and Imaging (2.4k citations) and Critical Care and Intensive Care Medicine (509 citations). Charles V. Pollack has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include W. Brian Gibler, Matthew T. Roe, Eric D. Peterson, E. Magnus Ohman, Judd E. Hollander, Anita Y. Chen, Sidney C. Smith, L. Kristin Newby, Robert A. Harrington and Deborah B. Diercks. Their work appears in journals such as Annals of Emergency Medicine, Journal of Emergency Medicine, Academic Emergency Medicine, American Heart Journal and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact